BMS-986089

BMS-986089 · Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BMS-986089, covering 2019-05-08 to 2019-05-08. Get the full timeline:

Most recent: Clinical Trial Update: Study of an Investigational Drug, RO7239361 (BMS-986089), in Ambulatory Boys With DMD [Phase 1, Phase 2]